Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Friday, with price target changes for multiple companies. DigitalOcean Holdings, ABM Industries, and Clarivate Plc saw price target cuts and downgrades, while Gilead Sciences, Adobe Inc., Delek Logistics Partners, Spruce Biosciences, Braze, Designer Brands, and G-III Apparel Group had their price targets increased. C3.ai had its price target slightly reduced.
September 08, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adobe Inc.'s price target was raised from $520 to $630 and the stock was upgraded from Neutral to Buy.
The increase in price target and upgrade in rating by Mizuho is likely to positively impact Adobe's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Braze's price target was boosted from $50 to $60, with a maintained Buy rating.
The increase in price target by Needham is likely to positively impact Braze's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Designer Brands' price target was increased from $8 to $14, with a maintained Market Perform rating.
The significant increase in price target by Telsey Advisory Group is likely to positively impact Designer Brands' stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
G-III Apparel Group's price target was boosted from $23 to $26, with a maintained Overweight rating.
The increase in price target by Keybanc is likely to positively impact G-III Apparel Group's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Gilead Sciences' price target was increased from $88 to $95 and the stock was upgraded from Neutral to Buy.
The increase in price target and upgrade in rating by B of A Securities is likely to positively impact Gilead Sciences' stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Spruce Biosciences' price target was increased from $3 to $9 and the stock was upgraded from Market Perform to Outperform.
The significant increase in price target and upgrade in rating by SVB Leerink is likely to positively impact Spruce Biosciences' stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
C3.ai's price target was slightly reduced from $29 to $28, with a maintained Neutral rating.
The slight reduction in price target by Piper Sandler is unlikely to have a significant impact on C3.ai's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Delek Logistics Partners' price target was cut from $47 to $45, but the stock was upgraded from Sell to Neutral.
The slight reduction in price target is offset by the upgrade in rating by Citigroup, leading to a neutral impact on Delek Logistics Partners' stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
ABM Industries' price target was slashed from $65 to $43 and the stock was downgraded from Buy to Hold.
The significant reduction in price target and downgrade in rating by Deutsche Bank is likely to negatively impact ABM Industries' stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Clarivate Plc's price target was lowered from $8 to $7 and the stock was downgraded from Equal-Weight to Underweight.
The reduction in price target and downgrade in rating by Barclays is likely to negatively impact Clarivate's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
DigitalOcean's price target was cut from $47 to $25 and the stock was downgraded from Buy to Underperform.
The significant cut in price target and downgrade in rating by B of A Securities is likely to negatively impact DigitalOcean's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100